ISRCTN95638591已完成未知
A Randomised Trial of 5-Fluorouracil (5FU) and Leucovorin (LV) versus 5-Fluorouracil, leucovorin and Interferon-Alpha 2a for Advanced Colorectal Adenocarcinoma
Medical Research Council (MRC) (UK)0 个研究点目标入组 260 人开始时间: 2002年8月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 260
研究概览
简要总结
1996 results in: https://www.ncbi.nlm.nih.gov/pubmed/8708718 (added 15/11/2019)
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Histologically confirmed adenocarcinoma of the colon or rectum not amenable to surgery or radiotherapy
- •2. Objectively assessable disease
- •3. No previous treatment with 5-fluorouracil or interferon
- •4. Adequate bone marrow function
- •5. No concurrent uncontrolled medical illness
- •6. Not on systemic corticosteroids at the time of study entry
- •7. Life expectancy of >3 months
- •8. World Health Organisation (WHO) performance status 0-2
排除标准
- •Not provided at time of registration.
研究者
相似试验
已完成
不适用
A randomised trial of adjuvant 5-fluorouracil, leucovorin and radiotherapy in colorectal adenocarcinomaColon, Rectal cancer1. Malignant neoplasm of colon2. Malignant neoplasm of rectumCancerISRCTN88796215Wyeth-Lederle Ltd (UK)
已完成
3 期
Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon CancerStage II Colon CancerStage III Colon CancerNCT00004931National Cancer Institute (NCI)2,472
已完成
不适用
A randomised trial of infusional 5-fluorouracil and concomitant radiotherapy in locally advanced rectal cancer, comparing three and six months of infusional 5-fluorouracilCancer of rectumCancerISRCTN93845533The Royal Marsden NHS Foundation Trust (UK)
进行中（未招募）
不适用
A Randomised Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Proapectively the Prognostic Value of Molecular MarkersEUCTR2007-001195-36-IEAll Ireland Cooperative Oncology Research Group (ICORG)3,610
终止
2 期
Trial of Infusional FOLFIRINOX in First Line Treatment of Advanced Biliary Tract CancersBiliary Tract CancerNCT03291899King Faisal Specialist Hospital & Research Center13